Sample result

GLP-1, a diabetes hormone

A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.

The search

Query: GLP-1 · 31 lettersHAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG
From: UniProt P01275, residues 98 to 128
Search: Protein → Patent proteins · Automatic (Smith-Waterman)
Set: Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
Ran: 2026-11-12
Found: 5,000 sequences, 3,061 publications, 1,851 families

Smith-Waterman compares each query with every stored sequence. Each query returns up to 5,000 sequences, with the best alignment of each. FASTA36 fits its E-values to a random sample of scores, so a sequence near the cutoff can come and go between runs. These results do not establish patentability.

Patents

3,061 publications in 1,851 families match these filters.

US 10471127-B22019-11-12

Peptide pharmaceuticals for insulin resistance

Mederis Diabetes, LLC

Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- US 10471127-B22019-11-12
- US 10577405-B22020-03-03
- US 11065304-B22021-07-20
- US 12551535-B22026-02-17
WO 2019243557-A12019-12-26

FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVITY RATIO

SANOFI SA

Query Match 96.3%Identity 100.0%Family of 6
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 6
Grouped by the same title and applicant. No priority claim is on record.
- WO 2019243557-A12019-12-26
- JP 2020504611-A2020-02-13
- US 10583174-B22020-03-10
- JP 2021528422-A2021-10-21
- JP 2024105462-A2024-08-06
- EP 4775592-A22026-07-15
JP 2020500163-A2020-01-09

METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM

PEPTRON INC, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2020501508-A2020-01-23

Multimers, Tetramers & Octamers

Quadrucept Bio Limited,Hanif ALI

Query Match 96.3%Identity 96.8%Family of 3
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || ||||||||||||||||||||||||||||
Hit    1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
Family of 3
Grouped by a shared priority claim, GB 1615768.7.
- JP 2020501508-A2020-01-23
- JP 2023015311-A2023-01-31
- JP 2025029067-A2025-03-05
WO 2020023386-A12020-01-30

GIP/GLP1 CO-AGONIST COMPOUNDS

LILLY CO ELI

Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020023386-A12020-01-30
- WO 2021150673-A12021-07-29
- EP 4549454-A22025-05-07
WO 2020023388-A12020-01-30

METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES

LILLY CO ELI

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020023388-A12020-01-30
- EP 4450127-A22024-10-23
JP 2020503884-A2020-02-06

RECOMBINANT VECTOR FOR EXPRESSING TARGET PROTEIN IN PLANT CELL

BIOAPPLICATIONS INC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2020503884-A2020-02-06
- US 11845945-B22023-12-19
US 10626156-B22020-04-21

Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020200057701-A2020-05-26

IGG FC VARIANTS FOR VETERINARY USE

KINDRED BIOSCIENCES, INC

Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         ||||||||||||||||||||||||||||| |
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGAG 31
```
30 of 31 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200057701-A2020-05-26
- EP 3668536-A12020-06-24
- JP 2020531002-A2020-11-05
- EP 3902564-A12021-11-03
KR 1020200061688-A2020-06-03

GLUCAGON-LIKE PEPTIDE-1 DERIVATIVE CONJUGATED WITH ALBUMIN

Gwangju Institute of Science and Technology

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 7 to 36. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    7 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 36
```
30 of 30 identical, no gaps.
EP 3663312-A12020-06-10

LONG-ACTING POLYPEPTIDES AND USES THEREOF

OPKO BIOLOGICS LTD

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020200075895-A2020-06-26

IMPROVED PEPTIDE PHARMACEUTICALS

MEDERIS DIABETES, LLC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200075895-A2020-06-26
- JP 2021020925-A2021-02-18
KR 1020200081411-A2020-07-07

ORAL DELIVERY OF GLP-1 PEPTIDE ANALOGS

MEDIMMUNE LIMITED

Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200081411-A2020-07-07
- EP 3703817-A22020-09-09
- JP 2021501172-A2021-01-14
- US 11173124-B22021-11-16
KR 1020200088418-A2020-07-22

INCRETIN ANALOGS AND USES THEREOF

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 13
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 13
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200088418-A2020-07-22
- KR 1020200088419-A2020-07-22
- JP 2021506825-A2021-02-22
- JP 2022033724-A2022-03-02
- JP 2022043082-A2022-03-15
- KR 1020220100676-A2022-07-15
- KR 1020220133304-A2022-10-04
- US 11542313-B22023-01-03
- JP 2023506952-A2023-02-20
- US 11834486-B22023-12-05
- JP 2025093970-A2025-06-24
- US 12365716-B22025-07-22
- US 12371465-B22025-07-29
WO 2020163125-A12020-08-13

GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME

LILLY CO ELI

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020200106173-A2020-09-11

IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS

MEDERIS DIABETES, LLC

Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200106173-A2020-09-11
- EP 4506017-A22025-02-12
- KR 1020250043579-A2025-03-28
WO 2020187711-A12020-09-24

MULTIMERS

QUADRUCEPT BIO LTD

Query Match 96.3%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || ||||||||||||||||||||||||||||
Hit    1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 10815203-B22020-10-27

Analogs of fexaramine and methods of making and using

Salk Institute for Biological Studies and The University of Sydney

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020200138084-A2020-12-09

Physiological active materials linked biotin moiety and composition for oral administration comprising the same

D&D Pharmatech Inc

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
EP 3764988-A12021-01-20

GEL-FORMING POLYPEPTIDES

ADEPTHERA LLC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2021021877-A12021-02-04

GIPR-AGONIST COMPOUNDS

LILLY CO ELI

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020210016632-A2021-02-16

GIP/GLP1 CO-AGONIST COMPOUNDS

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 11
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 11
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210016632-A2021-02-16
- JP 2021508731-A2021-03-11
- KR 1020210031533-A2021-03-19
- US 11084861-B22021-08-10
- JP 2021183614-A2021-12-02
- KR 1020220131292-A2022-09-27
- JP 2023511441-A2023-03-17
- JP 2023171775-A2023-12-05
- KR 1020240051304-A2024-04-19
- US 12252524-B22025-03-18
- JP 2026069790-A2026-04-24
WO 2021034815-A12021-02-25

METHODS OF MAKING INCRETIN ANALOGS

LILLY CO ELI

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020210024081-A2021-03-04

METHOD OF USING A GIP/GLP1 CO-AGONIST FOR DIABETES

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 8
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 8
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210024081-A2021-03-04
- JP 2021530544-A2021-11-11
- JP 2022177118-A2022-11-30
- JP 2024056852-A2024-04-23
- KR 1020240095310-A2024-06-25
- JP 2025063146-A2025-04-15
- US 12295987-B22025-05-13
- US 12453758-B22025-10-28
US 10947290-B22021-03-16

Method of stabilizing a bioactive peptide against protease hydrolysis

The Trustees of the University of Pennsylvania and President and Fellows of Harvard College

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2021509892-A2021-04-08

IMPROVED PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS

SPITFIRE PHARMA INC

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 10987427-B22021-04-27

Modified therapeutic agents and compositions thereof

THE SCRIPPS RESEARCH INSTITUTE

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 11007252-B22021-05-18

Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof

THE SCRIPPS RESEARCH INSTITUTE

Query Match 96.3%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- US 11007252-B22021-05-18
- US 11865160-B22024-01-09
- US 12337028-B22025-06-24
EP 3823659-A12021-05-26

PHARMACEUTICAL COMPOSITION COMPRISING POLYPEPTIDE

D&D PHARMATECH INC

Query Match 96.3%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- EP 3823659-A12021-05-26
- JP 2021530533-A2021-11-11
- JP 2023144098-A2023-10-06
- JP 2025178483-A2025-12-05
- JP 2026083391-A2026-05-19
US 11028123-B22021-06-08

Capping of unprotected amino groups during peptide synthesis

SANOFI-AVENTIS DEUTSCHLAND GMBH

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 11033607-B22021-06-15

Peptides and methods for preventing ischemic tissue injury

University Health Network

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2021126695-A12021-06-24

INCRETIN ANALOGS AND USES THEREOF

LILLY CO ELI

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020210092335-A2021-07-23

The method for delivering the neuroprotection polypeptide to the central nervous system

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 11103557-B22021-08-31

Exenatide analogue and use thereof

ANYGEN Co., Ltd.

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020210110252-A2021-09-07

Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease comprising a polypeptide

D&D Pharmatech Inc

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2021175974-A12021-09-10

PEPTIDES AS SELECTIVE GIP RECEPTOR AGONISTS

SANOFI SA

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
WO 2021190980-A12021-09-30

MULTIMERS FOR VIRAL STRAIN EVOLUTION

QUADRUCEPT BIO LTD

Query Match 96.3%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || ||||||||||||||||||||||||||||
Hit    1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
WO 2021212023-A12021-10-21

LONG ACTING PEPTIDE TYROSINE TYROSINE (PYY) ANALOGS AND METHODS OF USE

INTARCIA THERAPEUTICS INC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2021212023-A12021-10-21
- US 12122816-B22024-10-22
KR 1020210134245-A2021-11-09

NOVEL PROTEIN CONJUGATE AND ITS USE OF PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES

ONEGENE BIOTECHNOLOGY INC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020210134245-A2021-11-09
- JP 2023523288-A2023-06-02
KR 1020210151794-A2021-12-14

MULTIMERS

QUADRUCEPT BIO LIMITED

Query Match 96.3%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || ||||||||||||||||||||||||||||
Hit    1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
US 11246913-B22022-02-15

Suspension formulation comprising an insulinotropic peptide

Intarcia Therapeutics, Inc.

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
US 11254721-B22022-02-22

GIPR-agonist compounds

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 7
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 7
Grouped by the same title and applicant. No priority claim is on record.
- US 11254721-B22022-02-22
- KR 1020220028007-A2022-03-08
- JP 2022544061-A2022-10-17
- JP 2023062068-A2023-05-02
- US 11897926-B22024-02-13
- JP 2024150523-A2024-10-23
- KR 1020250065721-A2025-05-13
US 11273130-B22022-03-15

Methods of delivering a neuroprotective polypeptide to the central nervous system

The United States, as represented by the Secretary Department of Health and Human Services and Peptron, Inc.

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020220035199-A2022-03-21

METHODS OF MAKING INCRETIN ANALOGS

Eli Lilly and Company

Query Match 96.3%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 4
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220035199-A2022-03-21
- JP 2022545200-A2022-10-26
- JP 2024147650-A2024-10-16
- KR 1020250074694-A2025-05-27
JP 2022519620-A2022-03-24

GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME

Eli Lilly and Company

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
JP 2022524303-A2022-05-02

MULTIMERS

QUADRUCEPT BIO LIMITED

Query Match 96.3%Identity 96.8%
Best alignment
Query 1 to 31, hit 1 to 31. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
         || ||||||||||||||||||||||||||||
Hit    1 HAPGTFTSDVSSYLEGQAAKEFIAWLVKGRG 31
```
30 of 31 identical, no gaps.
KR 1020220074813-A2022-06-03

Physiological active materials conjugate with biotin moiety, fatty acid moiety or a combination thereof

D&D Pharmatech Inc

Query Match 96.3%Identity 100.0%
Best alignment
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
KR 1020220075189-A2022-06-07

Oral formulation of physiological active material conjugate linked with biotin moiety, fatty acid moiety or a combination thereof

D&D Pharmatech Inc

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220075189-A2022-06-07
- JP 2023551480-A2023-12-08
KR 1020220119474-A2022-08-29

STAPLED LACTAM CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

Merck Sharp & Dohme LLC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220119474-A2022-08-29
- JP 2023508347-A2023-03-02
KR 1020220119475-A2022-08-29

STAPLED TRIAZOLE CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS

Merck Sharp & Dohme LLC

Query Match 96.3%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 30, hit 1 to 30. Positions start at 1 and include both ends.
```
Query  1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
         ||||||||||||||||||||||||||||||
Hit    1 HAEGTFTSDVSSYLEGQAAKEFIAWLVKGR 30
```
30 of 30 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020220119475-A2022-08-29
- JP 2023508349-A2023-03-02

GLP-1, a diabetes hormone

The search

Patents

Family of 4

Family of 6

Family of 3

Family of 3

Family of 2

Family of 2

Family of 4

Family of 2

Family of 4

Family of 13

Family of 3

Family of 11

Family of 8

Family of 3

Family of 5

Family of 2

Family of 2

Family of 7

Family of 4

Family of 2

Family of 2

Family of 2